CTI BioPharma (CTIC)

P/S ratio on August 25, 2023 (TTM) : 15.8

According to CTI BioPharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -47.3. At the end of 2023 the company had a P/S ratio of 7.31.

P/S ratio history for CTI BioPharma from 2001 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	7.31	-48.3%
2022	14.1
2021	N/A
2020	N/A	-100%
2019	27.4	1568.81%
2018	1.64	-64.16%
2017	4.58	128.47%
2016	2.00	-90.64%
2015	21.4	208.27%
2014	6.94	-13.36%
2013	8.01
2012	N/A
2011	N/A	-100%
2010	931	-88.93%
2009	> 1000	1174734.83%
2008	0.7160	-99.91%
2007	761	-75.95%
2006	> 1000	32410.49%
2005	9.73	-42.02%
2004	16.8	41.05%
2003	11.9	-15.38%
2002	14.1	-89.23%
2001	131

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Amgen AMGN	4.37	-72.38%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.47	-84.39%	🇺🇸 USA
Incyte INCY	3.30	-79.11%	🇺🇸 USA
Baxter BAX	1.06	-93.29%	🇺🇸 USA
Eli Lilly LLY	17.5	10.68%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	1.51	-90.43%	🇮🇱 Israel
Novartis NVS	3.94	-75.11%	🇨🇭 Switzerland

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for CTI BioPharma (CTIC)

P/S ratio on August 25, 2023 (TTM) : 15.8